Probiotic Therapy in the Prevention of Pouchitis Onset: Decreased Interleukin-1β, Interleukin-8, and Interferon-γ Gene Expression
- 1 May 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 11 (5) , 447-454
- https://doi.org/10.1097/01.mpa.0000160302.40931.7b
Abstract
Background. Probiotic therapy has been shown to prevent the onset of pouchitis and to improve the quality of life in ulcerative colitis patients who required iKeywords
This publication has 33 references indexed in Scilit:
- Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII International Small Bowel Transplant SymposiumTransplantation Proceedings, 2004
- Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatmentAmerican Journal of Gastroenterology, 2001
- Resolution of inflammationInternational Journal of Immunopharmacology, 2000
- Antibiotic therapy attenuates colitis in interleukin 10 gene–deficient miceGastroenterology, 2000
- Increased state of activation of CD4 positive T cells and elevated interferon γ production in pouchitisGut, 1998
- Experimental models of inflammatory bowel diseaseGastroenterology, 1995
- Cytokine production in pouchitis is similar to that in ulcerative colitisDiseases of the Colon & Rectum, 1995
- Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouchesDigestive Diseases and Sciences, 1994
- Pouchitis: result of microbial imbalance?Gut, 1994
- Double blind, placebo controlled trial of metronidazole in Crohn's disease.Gut, 1991